Rybelsus
RxNorm concept 2200645, brand name (bn).
- RxCUI
- 2200645
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2200645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- semaglutide 14 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide Oral Tablet [Rybelsus] (SBDF, ingredient of)
- Rybelsus Oral Product (SBDG, ingredient of)
- Rybelsus Pill (SBDG, ingredient of)
- semaglutide 14 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide 3 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide 3 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide 7 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide 7 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide 1.5 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide 1.5 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide 4 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide 4 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide 9 MG [Rybelsus] (SBDC, ingredient of)
- semaglutide 9 MG Oral Tablet [Rybelsus] (SBD, ingredient of)
- semaglutide (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2200645 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2200645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2200645. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.